Related Experiment Video

Updated: May 18, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

[Eph family receptors as therapeutic targets]

S A Zozulya, I P Udovichenko

    Bioorganicheskaia Khimiia
    |September 25, 2012
    PubMed

    Insights

    Targeting Eph-ephrin signaling offers new anti-angiogenic therapies for cancer. This approach addresses limitations of current treatments by exploring novel molecular targets in angiogenesis and tumor growth.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Biochemistry

    Context:

    • Aberrant neovascularization drives cancer progression and other pathologies.
    • Existing anti-angiogenic therapies targeting vascular endothelial growth factor (VEGF) have limitations.
    • Novel molecular targets are crucial for advancing cancer treatment.

    Purpose:

    • To review the biological functions of Eph receptor tyrosine kinases and ephrin ligands.
    • To discuss therapeutic strategies targeting Eph-ephrin signaling for anti-angiogenic and anti-tumor activity.
    • To explore the role of Eph-ephrin signaling in cancer cell proliferation and invasion.

    Summary:

    • The Eph-ephrin signaling pathway plays a significant role in normal and pathological angiogenesis.
    • Modulating Eph-ephrin interactions presents a promising strategy for developing novel anti-cancer therapeutics.
    • Understanding Eph-ephrin's function in cancer cell proliferation and invasion is key to targeted therapy development.

    Impact:

    • Identifies Eph-ephrin signaling as a critical target for new anti-angiogenic drugs.
    • Provides a foundation for developing therapeutics with both anti-angiogenic and direct anti-tumor effects.
    • Highlights the potential for personalized medicine by targeting specific Eph-ephrin interactions in cancer.

    More Related Videos

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis03:23

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

    Published on: May 10, 2024

    Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

    Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

    Published on: July 26, 2017

    Related Concept Videos

    Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

    Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

    Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
    Transducer Mechanism: Enzyme-Linked Receptors01:27

    Transducer Mechanism: Enzyme-Linked Receptors

    Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
    Major types that are helpful drug targets include:
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
    G Protein-coupled Receptors01:15

    G Protein-coupled Receptors

    G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
    GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...